DP
ARVN icon

DSAM Partners’s Arvinas ARVN Stock Holding History

DSAM Partners’s Portfolio ARVN Stock Details ARVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-10,075
Closed -$129K – 89
2018
Q4 		$129K Buy
+10,075
New +$160K 0.03% 36

Other funds holding ARVN

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DSAM Partners's ARVN Position: Q1 2019 in Review

DSAM Partners sold out of Arvinas (ARVN) in Q1 2019, closing a stake of 10,075 shares — an estimated $129K sold.

DSAM Partners first reported a position in ARVN in Q4 2018 and held it in 1 quarter. The position peaked at $129K in Q4 2018. 57 funds tracked by Wall St. Rank hold ARVN as of Q1 2019.

  • DSAM Partners reported no remaining Arvinas position as of Q1 2019 after selling out during the quarter.
  • DSAM Partners sold 10,075 Arvinas shares in Q1 2019, an estimated $129K.
  • DSAM Partners first reported a position in Arvinas in Q4 2018 and held it in 1 quarter.
  • DSAM Partners's Arvinas position peaked at $129K in Q4 2018.
  • 57 funds tracked by Wall St. Rank held Arvinas as of Q1 2019.

Based on DSAM Partners's 13F filing for Q1 2019, filed 15 May 2019.